|
|
|
|
|
| Recent Announcements |
|
8th Annual Nanotechnology and Sustainability Venture Forum
Ensysce Biosciences to present at 8th Annual Nanotechnology and Sustainability Venture Forum |
|
READ MORE |
|
|
|
"Nanotechnology: The Opportunity for Cancer Treatment"
Bob Gower to give Keynote Speech at Chemical Heritage Society's Joseph Priestly Society Symposium. |
|
| READ MORE |
|
|
|
| Ensysce Biosciences Inc. Appoints Dr. D. Lynn Kirkpatrick as President and CEO. |
|
| READ MORE |
|
|
|
|
|
|
|
| |
| Recent Announcements |
|
| Presentation Nov. 10, 2009 |
|
| READ FULL ARTICLE |
|
| Safety of single-walled carbon nanotubes for delivery of siRNA |
|
D. Lynn Kirkpatrick, Geoffrey Bartholomeusz, Michelle Weiss, Dmitri Tsyboulski, Saunab Ghosh, Anton Naumov, R. Bruce Weisman.
Ensysce Biosciences. Inc., Houston, TX, UT MD Anderson Cancer Center, Houston, TX, Rice University, Houston, TX
READ FULL ARTICLE |
|
| 8th Annual Nanotechnology and Sustainability Venture Forum |
|
Ensysce Biosciences to present at 8th Annual Nanotechnology and Sustainability Venture Forum
READ FULL ARTICLE |
|
| Jan 8, 2009 : "Nanotechnology: The Opportunity for Cancer Treatment" |
|
Bob Gower to give Keynote Speech at Chemical Heritage Society's Joseph Priestly Society Symposium.
READ FULL ARTICLE |
|
| Jan 5, 2009: Ensysce Biosciences Inc. Appoints Dr. D. Lynn Kirkpatrick as President and CEO. |
|
Houston, TX, Jan 5, 2009 - Ensysce Biosciences Inc. announced today the appointment of Dr. Lynn Kirkpatrick as President and CEO. Dr. Kirkpatrick has an extensive background in targeted small molecule cancer drug development, and has brought three agents from bench to bedside.
READ FULL ARTICLE |
|
|
|
|
|
|
|
